HFF, Inc. Class A Common Stock Underwriting Agreement
Exhibit 1.1
Class A Common Stock
[ ], 2007
Xxxxxxx, Xxxxx & Co.
Xxxxxx Xxxxxxx & Co. Incorporated
As representatives of the several Underwriters
named in Schedule I hereto,
c/o Goldman, Sachs & Co.
00 Xxxxx Xxxxxx,
Xxx Xxxx, Xxx Xxxx 00000
and
Xxxxxx Xxxxxxx & Co. Incorporated,
0000 Xxxxxxxx,
Xxx Xxxx, Xxx Xxxx 00000
Xxxxxx Xxxxxxx & Co. Incorporated
As representatives of the several Underwriters
named in Schedule I hereto,
c/o Goldman, Sachs & Co.
00 Xxxxx Xxxxxx,
Xxx Xxxx, Xxx Xxxx 00000
and
Xxxxxx Xxxxxxx & Co. Incorporated,
0000 Xxxxxxxx,
Xxx Xxxx, Xxx Xxxx 00000
Ladies and Gentlemen:
HFF, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and
conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the
“Underwriters”) an aggregate of [___] shares (the “Firm Shares”) and, at the election of the
Underwriters, up to [___] additional shares (the “Optional Shares”) of Class A Common Stock, par
value $0.01 per share (“Stock”) of the Company (the Firm Shares and the Optional Shares that the
Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the
“Shares”).
Xxxxxx Xxxxxxx & Co. Incorporated (“Xxxxxx Xxxxxxx”) has agreed to reserve a portion of the
Shares to be purchased by it under this Agreement for sale to the Company’s directors, officers and
employees and family members of such persons (collectively, “Participants”), as set forth in the
Prospectus under the heading “Underwriting” (the “Directed Share Program”). The Shares to be sold
by Xxxxxx Xxxxxxx and its affiliates pursuant to the Directed Share Program are referred to
hereinafter as the “Directed Shares”. Any Directed Shares not orally confirmed for purchase by any
Participant by the end of the business day on which this Agreement is executed will be offered to
the public by the Underwriters as set forth in the Prospectus.
As used in this Agreement, the term “Xxxxxxxx Xxxxxxxx Xxxxxx” refers to Xxxxxxxx Xxxxxxxx
Xxxxxx, X.X., a Texas limited partnership; the term “HFF Securities” refers to HFF Securities L.P.,
a Delaware limited partnership; the term “Partnerships” refers collectively to Xxxxxxxx Xxxxxxxx
Xxxxxx and HFF Securities; the term “Partnership Holdings” refers to HFF Partnership Holdings LLC,
a Delaware limited liability company; and the term “Xxxxxxxx XX” refers to Xxxxxxxx XX Corp., a
Delaware corporation and the sole general partner of each of the Partnerships.
Prior to the execution of this Agreement, the Company, HFF Holdings LLC, Xxxxxxxx XX, HFF LP
Acquisition LLC, GP Acquisition Corp. and Partnership Holdings have entered into that certain Sale
and Merger Agreement, dated as of [___], 2007 (the “Reorganization Agreement”). Pursuant to the
Reorganization Agreement and simultaneously with the purchase and sale of the Shares pursuant to
this Agreement, the Company and other parties to the Reorganization Agreement will consummate the
transactions contemplated in the Reorganization Agreement (such transactions, collectively, the
“Reorganization Transactions”), which transactions are further described in the Pricing Prospectus
(as such term is defined herein).
For all purposes of this Agreement, including without limitation, representations, warranties,
covenants and agreements of the Company and the Partnerships contained herein, Partnership
Holdings, Xxxxxxxx XX and the Partnerships shall be deemed to be subsidiaries of the Company as of
the date of this Agreement and at all times subsequent thereto.
1. The Company, Xxxxxxxx Xxxxxxxx Xxxxxx and HFF Securities jointly and severally represent
and warrant to, and agree with, each of the Underwriters that:
(a) A registration statement on Form S-1 (File No. 333-138579) (the “Initial Registration
Statement”) in respect of the Shares has been filed with the Securities and Exchange Commission
(the “Commission”); the Initial Registration Statement and any post-effective amendment thereto,
each in the form heretofore delivered to you, and, excluding exhibits thereto, to you for each of
the other Underwriters, have been declared effective by the Commission in such form; other than a
registration statement, if any, increasing the size of the offering (a “Rule 462(b) Registration
Statement”), filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended (the
“Act”), which became effective upon filing, no other document with respect to the Initial
Registration Statement has heretofore been filed with the Commission; and no stop order suspending
the effectiveness of the Initial Registration Statement, any post-effective amendment thereto or
the Rule 462(b) Registration Statement, if any, has been issued and no proceeding for that purpose
has been initiated or threatened by the Commission (any preliminary prospectus included in the
Initial Registration Statement or filed with the Commission pursuant to Rule 424(a) under the Act
is hereinafter called a
2
“Preliminary Prospectus”; the various parts of the Initial Registration Statement and the Rule
462(b) Registration Statement, if any, including all exhibits thereto and including the information
contained in the form of final prospectus filed with the Commission pursuant to Rule 424(b) under
the Act in accordance with Section 5(a) hereof and deemed by virtue of Rule 430A under the Act to
be part of the Initial Registration Statement at the time it was declared effective, each as
amended at the time such part of the Initial Registration Statement became effective or such part
of the Rule 462(b) Registration Statement, if any, became or hereafter becomes effective, are
hereinafter collectively called the “Registration Statement”; the Preliminary Prospectus relating
to the Shares that was included in the Registration Statement immediately prior to the Applicable
Time (as defined in Section 1(c) hereof) is hereinafter called the “Pricing Prospectus”; such final
prospectus, in the form first filed pursuant to Rule 424(b) under the Act, is hereinafter called
the “Prospectus”; and any “issuer free writing prospectus” as defined in Rule 433 under the Act
relating to the Shares is hereinafter called an “Issuer Free Writing Prospectus”);
(b) No order preventing or suspending the use of any Preliminary Prospectus or any Issuer Free
Writing Prospectus has been issued by the Commission, and each Preliminary Prospectus, at the time
of filing thereof, conformed in all material respects to the requirements of the Act and the rules
and regulations of the Commission thereunder, and did not contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading;
provided, however, that this representation and warranty shall not apply to any statements or
omissions made in reliance upon and in conformity with information furnished in writing to the
Company by an Underwriter through Xxxxxxx, Sachs & Co. and Xxxxxx Xxxxxxx & Co. Incorporated
(collectively, the “Lead Representatives”) expressly for use therein;
(c) For the purposes of this Agreement, the “Applicable Time” is [___:___m.] (Eastern time)
on the date of this Agreement. The Pricing Prospectus, as of the Applicable Time, did not include
any untrue statement of a material fact or omit to state any material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made, not
misleading; and each Issuer Free Writing Prospectus listed on Schedule II(a) hereto does not
conflict with the information contained in the Registration Statement, the Pricing Prospectus or
the Prospectus and each such Issuer Free Writing Prospectus, as supplemented by and taken together
with the Pricing Prospectus as of the Applicable Time, did not include any untrue statement of a
material fact or omit to state any material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading; provided,
however, that this representation and warranty shall not apply to statements or omissions
made in an Issuer Free Writing Prospectus in reliance upon and in
3
conformity with information furnished in writing to the Company by an Underwriter through the
Lead Representatives expressly for use therein;
(d) The Registration Statement conforms, and the Prospectus and any further amendments or
supplements to the Registration Statement and the Prospectus will conform, in all material respects
to the requirements of the Act and the rules and regulations of the Commission thereunder and do
not and will not, as of the applicable effective date as to each part of the Registration Statement
and as of the applicable filing date as to the Prospectus and any amendment or supplement thereto,
contain an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not misleading; provided,
however, that this representation and warranty shall not apply to any statements or
omissions made in reliance upon and in conformity with information furnished in writing to the
Company by an Underwriter through the Lead Representatives expressly for use therein;
(e) Neither the Company nor the Partnerships nor any of their respective subsidiaries has
sustained since the date of the latest audited financial statements included in the Pricing
Prospectus any material loss or interference with its business from fire, explosion, flood or other
calamity, whether or not covered by insurance, or from any labor dispute or court or governmental
action, order or decree, otherwise than as set forth or contemplated in the Pricing Prospectus;
and, since the respective dates as of which information is given in the Registration Statement and
the Pricing Prospectus, there has not been any change in the capital stock or long-term debt of the
Company, the Partnerships or any of their respective subsidiaries or any material adverse change,
or any development involving a prospective material adverse change, in the general affairs,
management, financial position, stockholders’ equity or results of operations of the Company, the
Partnerships and their respective subsidiaries, otherwise than as set forth or contemplated in the
Pricing Prospectus;
(f) Neither the Company nor the Partnerships nor any of their respective subsidiaries own any
real property. The Company, the Partnerships and their respective subsidiaries have good and
marketable title to all personal property owned by them and material to the Company and its
subsidiaries, taken as a whole, free and clear of all liens, encumbrances and defects except such
as are described in the Pricing Prospectus or such as do not materially interfere with the use made
and proposed to be made of such property by the Company, the Partnerships and their respective
subsidiaries; and any real property and buildings held under lease by the Company, the Partnerships
and their respective subsidiaries are held by them under valid, subsisting and enforceable leases
with such exceptions as are not material and do not interfere with the use made and proposed to be
made of such property and buildings by the Company, the Partnerships and their respective
subsidiaries;
4
(g) The Company has been duly incorporated and is validly existing as a corporation in good
standing under the laws of the State of Delaware, with power and authority (corporate and other) to
own its properties and conduct its business as described in the Pricing Prospectus, and has been
duly qualified as a foreign corporation for the transaction of business and is in good standing
under the laws of each other jurisdiction in which it owns or leases properties or conducts any
business so as to require such qualification, except where any such failure to be so qualified or
be in good standing would not, individually or in the aggregate, have a material adverse effect on
the condition (financial or otherwise), business, properties or results of operations of the
Company and its subsidiaries taken as a whole (a “Material Adverse Effect”); each of Xxxxxxxx
Xxxxxxxx Xxxxxx and HFF Securities has been duly organized and is validly existing as a limited
partnership in good standing under the laws of the State of Delaware or the State of Texas, as the
case may be, with power and authority to own its properties and conduct its business as described
in the Pricing Prospectus, and has been duly qualified as a foreign limited partnership for the
transaction of business and is in good standing under the laws of each other jurisdiction in which
it owns or leases properties or conducts any business so as to require such qualification, except
where any such failure to be so qualified or be in good standing would not, individually or in the
aggregate, have a Material Adverse Effect; and each subsidiary of the Company and the Partnerships
has been duly incorporated or organized and is validly existing as a corporation, limited liability
company or partnership, as the case may be, in good standing under the laws of its jurisdiction of
incorporation or organization, as the case may be;
(h) The Company has an authorized capitalization as set forth in the Pricing Prospectus and
all of the issued shares of capital stock of the Company have been duly and validly authorized and
issued and are fully paid and non-assessable and conform to the description of the Stock contained
in the Pricing Prospectus and Prospectus; the partnership interests of the Partnerships to be
issued to the Company or its wholly-owned subsidiaries in connection with the Reorganization
Transactions will be duly authorized and validly issued and will be owned by the Company or its
wholly-owned subsidiaries free and clear of all liens, encumbrances, equities or claims; and all of
the issued shares of capital stock or other equity interests of each subsidiary of the Company and
the Partnerships owned directly or indirectly by the Company or the Partnerships, as the case may
be, have been duly authorized and validly issued, and, to the extent such concept is applicable,
are fully paid and non-assessable and are owned directly or indirectly by the Company or the
Partnerships, as the case may be, free and clear of all liens, encumbrances, equities or claims,
except for any lien or encumbrance in connection with that certain Credit Agreement, dated as of
March 29, 2006, by and among Xxxxxxxx Xxxxxxxx Xxxxxx, HFF Holdings LLC and Bank of America, N.A.;
5
(i) The unissued Shares to be issued and sold by the Company to the Underwriters hereunder
have been duly and validly authorized and, when issued and delivered against payment therefor as
provided herein, will be duly and validly issued and fully paid and non-assessable and will conform
in all material respects to the description of the Stock contained in the Prospectus;
(j) The issue and sale of the Shares and the compliance by the Company and the Partnerships
with this Agreement and the consummation of the transactions herein contemplated, including,
without limitation, the Reorganization Transactions, will not (i) conflict with or result in a
breach or violation of any of the terms or provisions of, or constitute a default under, any
indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the
Company, the Partnerships or any of their respective subsidiaries is a party or by which the
Company, the Partnerships or any of their respective subsidiaries is bound or to which any of the
property or assets of the Company, the Partnerships or any of their respective subsidiaries is
subject, (ii) result in any violation of the provisions of the Certificate of Incorporation or
By-laws of the Company or the limited partnership agreements of the Partnerships or (iii) result in
any violation of any statute or any order, rule or regulation of any court or governmental agency
or body having jurisdiction over the Company, the Partnerships or any of their respective
subsidiaries or any of their properties, except, in the case of clause (i) above, for any such
conflict, breach or violation that would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect; and no consent, approval, authorization, order,
registration or qualification of or with any such court or governmental agency or body is required
for the issue and sale of the Shares or the consummation by the Company and the Partnerships of the
transactions contemplated by this Agreement, including, without limitation, the Reorganization
Transactions, except the registration under the Act and the Securities Exchange Act of 1934, as
amended (the “Exchange Act”) of the Shares and such consents, approvals, authorizations,
registrations or qualifications as have already been obtained or made or as may be required by the
rules and regulations of the National Association of Securities Dealers, Inc. (the “NASD”) or under
applicable state securities or Blue Sky laws in connection with the purchase and distribution of
the Shares by the Underwriters;
(k) Neither the Company nor the Partnerships nor any of their subsidiaries is (i) in violation
of its Certificate of Incorporation, By-laws, limited partnership agreement, limited liability
company agreement or similar organizational documents or (ii) in default in the performance or
observance of any material obligation, agreement, covenant or condition contained in any indenture,
mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which it is a
party or by which it or any of its properties may be bound, except, in the case of clause (ii)
above, for any such default that would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect;
6
(l) The statements set forth in the Pricing Prospectus and Prospectus under the caption
“Description of Capital Stock”, insofar as they purport to constitute a summary of the terms of the
Stock, under the captions “Organizational Structure”, “Business Regulation”, “Management”, “Related
Party Transactions”, “Shares Eligible for Future Sale”, “Material U.S. Federal Tax Considerations
for Non-U.S. Holders of Class A Common Stock” and “Underwriting” , and in Part II, Item 14 of the
Registration Statement, insofar as they purport to describe the provisions of the laws and
documents referred to therein, are accurate, complete and fair;
(m) Other than as set forth in the Pricing Prospectus, there are no legal or governmental
proceedings pending to which the Company, the Partnerships or any of their respective subsidiaries
is a party or of which any property of the Company, the Partnerships or any of their respective
subsidiaries is the subject which, if determined adversely to the Company, the Partnerships or any
of their respective subsidiaries, would, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect; and, to the Company’s and the Partnerships’ knowledge, no such
proceedings are threatened or contemplated by governmental authorities or threatened by others;
(n) The Company is not and, after giving effect to the offering and sale of the Shares and the
application of the proceeds thereof, will not be an “investment company”, as such term is defined
in the Investment Company Act of 1940, as amended (the “Investment Company Act”);
(o) At the time of filing the Initial Registration Statement, the Company was not and is not
an “ineligible issuer,” as defined under Rule 405 under the Act;
(p) Ernst & Young LLP, who have certified certain financial statements of the Company and its
subsidiaries, are an independent registered public accounting firm as required by the Act and the
rules and regulations of the Commission thereunder;
(q) The Company maintains a system of internal control over financial reporting (as such term
is defined in Rule 13a-15(f) under the Exchange Act) that complies with the requirements of the
Exchange Act and has been designed by the Company’s principal executive officer and principal
financial officer, or under their supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles. The Company’s internal
control over financial reporting is effective and the Company is not aware of any material
weaknesses in its internal control over financial reporting;
(r) Since the date of the latest financial statements included in the Pricing Prospectus,
there has been no change in the Company’s internal control over
7
financial reporting that has materially affected, or is reasonably likely to materially
affect, the Company’s internal control over financial reporting;
(s) The Company maintains disclosure controls and procedures (as such term is defined in Rule
13a-15(e) under the Exchange Act) that comply with the requirements of the Exchange Act; such
disclosure controls and procedures have been designed to ensure that material information relating
to the Company and its subsidiaries is made known to the Company’s principal executive officer and
principal financial officer by others within those entities; and such disclosure controls and
procedures are effective;
(t) There are no off-balance sheet arrangements (as defined in Regulation S-K Item
303(a)(4)(ii)) that may have a material current or future effect on the Company’s financial
condition, changes in financial condition, results of operations, liquidity, capital expenditures
or capital resources;
(u) The historical financial statements of the Company and the consolidated historical
financial statements of HFF Holdings LLC (the “Predecessor”) and the related notes thereto included
in the Pricing Prospectus and the Prospectus present fairly, in all material respects, the
financial position, results of operations and cash flows of the Company and the Predecessor as of
the dates and for the periods indicated in conformity with accounting principles generally accepted
in the United States applied on a consistent basis throughout the periods involved (except as
described in the notes to such financial statements and, in the case of unaudited financial
statements, as permitted by the applicable rules of the Commission) and comply as to form in all
material respects with the applicable accounting requirements of the Act and the related published
rules and regulations; and the selected financial data set forth under the captions “Selected
Consolidated Financial Data” and “Summary Consolidated Financial and Other Data” in the Pricing
Prospectus and the Prospectus has been derived from the accounting records of the Company and/or
the Predecessor and present fairly, in all material respects, on the basis stated in the Pricing
Prospectus and the Prospectus, the information included therein;
(v) The pro forma financial statements included in the Pricing Prospectus and the Prospectus
include assumptions that provide a reasonable basis for presenting the significant effects directly
attributable to the transactions and events described therein, the related pro forma adjustments
give appropriate effect to those assumptions, and the pro forma adjustments reflect the proper
application of those adjustments to the historical financial statement amounts in the pro forma
financial statements included in the Pricing Prospectus and the Prospectus. The pro forma financial
statements included in the Pricing Prospectus and the Prospectus comply as to form in all material
respects with the applicable requirements of Regulation S-X under the Act;
(w) The Company, the Partnerships and their respective subsidiaries are in compliance in all
material respects with all presently applicable provisions of the
8
Employee Retirement Income Security Act of 1974, as amended, including the regulations and
published interpretations thereunder (“ERISA”); no “reportable event” (as defined in Section 4043
of ERISA) has occurred with respect to any “pension plan” (as defined in Section 3(2) of ERISA) for
which the Company, the Partnerships or any of their respective subsidiaries would have any material
liability; no “prohibited transaction” within the meaning of Section 406 of ERISA) has occurred
with respect to any “employee benefit plan” (within the meaning of Section 3(3) of ERISA) for which
the Company, the Partnerships or any of their respective subsidiaries would have any material
liability; neither the Company, the Partnerships nor any member of their “controlled group”
(defined as any organization which is a member of a controlled group of corporations within the
meaning of Section 414 of the Internal Revenue Code of 1986, as amended, including the regulations
and published interpretations thereunder, the “Code”) has incurred or expects to incur material
liability under (i) Title IV of ERISA with respect to any “pension plan” or (ii) Sections 412 or
4971 of the Code; and each “pension plan” for which the Company, the Partnerships or any of their
respective subsidiaries would have any liability that is intended to be qualified under Section
401(a) of the Code, has received a favorable determination letter from the Internal Revenue Service
and nothing has occurred, whether by action or by failure to act, which would reasonably be
expected to cause the loss of such qualification;
(x) Neither the Company nor the Partnerships nor any of their respective subsidiaries, nor, to
the knowledge of the Company, any of the directors, officers, employees or agents of, or other
persons associated with or acting on behalf of, the Company, the Partnerships or any of their
respective subsidiaries, (1) has used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expense relating to political activity, except as would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; (2)
made any direct or indirect unlawful payment to any foreign or domestic government official or
employee from corporate funds; or (3) made any unlawful bribe, rebate, payoff, influence payment,
kickback or other unlawful payment;
(y) There is and has been no failure on the part of the Company or any of the Company’s
officers or directors, in their capacities as such, to comply in all material respects with any
applicable provisions of the Sarbanes Oxley Act of 2002 and the rules and regulations promulgated
in connection therewith that are applicable to the Company as of the date hereof;
(z) The Company, the Partnerships and each of their respective subsidiaries carry, or are
covered by, insurance from insurers of recognized financial responsibility in such amounts and
covering such risks as the Company, the Partnerships and each of their respective subsidiaries
believes to be reasonable for the conduct of their respective businesses and the value of their
respective properties and as is customary for companies engaged in similar businesses in similar
industries;
9
(aa) Except as disclosed in the Pricing Prospectus and the Prospectus, the Company, the
Partnerships and each of their respective subsidiaries have such permits, licenses, consents,
exemptions, authorizations and other approvals (each, an “Authorization”) of, and have or will have
made all filings with and notices to, all Governmental Agencies as are necessary to conduct their
respective businesses, except where the failure to possess such Authorizations or make such filings
or notices would not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect; each such Authorization is valid and in full force and effect and the Company, the
Partnerships and each of their respective subsidiaries are, as of the date hereof, in compliance in
all material respects with all the terms and conditions thereof and with the applicable rules and
regulations of the Governmental Agencies having jurisdiction with respect thereto;
(bb) None of the Company, the Partnerships or any of their respective subsidiaries (other than
HFF Securities) is, or will as a result of the Reorganization Transactions be, required to register
as a broker-dealer under the Exchange Act and the rules and regulations of the Commission
thereunder or the securities laws of any state. No officer, partner or employee of the Company, the
Partnerships or any of their respective subsidiaries is, or will as a result of the Reorganization
Transactions be, required to register as a broker-dealer under the Exchange Act and the rules and
regulations of the Commission thereunder or the securities laws of any state, other than such
officers, partners and employees of the Company or any of its subsidiaries who are so registered
under the Exchange Act on the date hereof. HFF Securities is duly registered, licensed and
qualified as a broker-dealer under the Exchange Act and the rules and regulations of the Commission
thereunder and the securities laws of each state where the conduct of its business requires such
registration; and is duly registered and is in good standing with the NASD. No consent, approval,
authorization, order, registration or qualification of or with the NASD is required for the issue
and sale of the Shares or the consummation by the Company and the Partnerships of the transactions
contemplated by this Agreement, including, without limitation, the Reorganization Transactions,
except for such consents, approvals, authorizations, orders, registrations or qualifications as
have been obtained and are in full force and effect;
(cc) None of the Company, the Partnerships or any of their respective subsidiaries is, or will
as a result of the Reorganization Transactions be, required to register as an investment adviser
under the Advisers Act, or be registered, licensed or qualified as an investment adviser under the
laws requiring any such registration, licensing or qualification in any state in which it conducts
business;
(dd) The Company, the Partnerships and their respective subsidiaries own or possess, or can
acquire on reasonable terms, all material patents, patent rights, licenses, inventions, copyrights,
know-how (including trade secrets and other unpatented and/or unpatentable proprietary or
confidential information,
10
systems or procedures), trademarks, service marks and trade names currently employed by them
in connection with the business now operated by them, and neither the Company, nor the Partnerships
nor any of their respective subsidiaries have received any written notice of infringement of or
conflict with asserted rights of others with respect to any of the foregoing;
(ee) The Company has not taken, directly or indirectly, any action designed to or that has
constituted or that could reasonably be expected to cause or result in the unlawful stabilization
or manipulation of the price of any security of the Company to facilitate the sale or resale of the
shares of the Stock;
(ff) The Shares have been approved for listing on New York Stock Exchange (the “Exchange”)
subject to official notice of issuance;
(gg) The Registration Statement, the Prospectus, the Time of Sale Prospectus and any
preliminary prospectus comply, and any amendments or supplements thereto will comply, with any
applicable laws or regulations of foreign jurisdictions in which the Prospectus, the Pricing
Prospectus or any preliminary prospectus, as amended or supplemented, if applicable, are
distributed in connection with the Directed Share Program;
(hh) No consent, approval, authorization or order of, or qualification with, any governmental
body or agency, other than those obtained, is required in connection with the offering of the
Directed Shares in any jurisdiction where the Directed Shares are being offered; and
(ii) The Company has not offered, or caused Xxxxxx Xxxxxxx to offer, Shares to any person
pursuant to the Directed Share Program with the specific intent to unlawfully influence (ii) a
customer or supplier of the Company to alter the customer’s or supplier’s level or type of business
with the Company, or (ii) a trade journalist or publication to write or publish favorable
information about the Company or its products.
2. Subject to the terms and conditions herein set forth, (a) the Company agrees to issue and
sell to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly,
to purchase from the Company, at a purchase price per share of $[___] the number of Firm Shares
set forth opposite the name of such Underwriter in Schedule I hereto and (b) in the event and to
the extent that the Underwriters shall exercise the election to purchase Optional Shares as
provided below, the Company agrees to issue and sell to each of the Underwriters, and each of the
Underwriters agrees, severally and not jointly, to purchase from the Company, at the purchase price
per share set forth in clause (a) of this Section 2, that portion of the number of Optional Shares
as to which such election shall have been exercised (to be adjusted by you so as to eliminate
fractional shares) determined by multiplying such number of Optional Shares by a fraction, the
numerator of which is the maximum number of Optional Shares which such Underwriter is entitled to
purchase as set forth opposite the name of such
11
Underwriter in Schedule I hereto and the denominator of which is the maximum number of
Optional Shares that all of the Underwriters are entitled to purchase hereunder.
The Company hereby grants to the Underwriters the right to purchase at their election up to
[___] Optional Shares, at the purchase price per share set forth in the paragraph above, for
the sole purpose of covering sales of shares in excess of the number of Firm Shares, provided that
the purchase price per Optional Share shall be reduced by an amount per share equal to any
dividends or distributions declared by the Company and payable on the Firm Shares but not payable
on the Optional Shares. Any such election to purchase Optional Shares may be exercised only by
written notice from the Lead Representatives to the Company, given within a period of 30 calendar
days after the date of this Agreement, setting forth the aggregate number of Optional Shares to be
purchased and the date on which such Optional Shares are to be delivered, as determined by the Lead
Representatives but in no event earlier than the First Time of Delivery (as defined in Section 4
hereof) or, unless the Lead Representatives and the Company otherwise agree in writing, earlier
than two or later than ten business days after the date of such notice.
3. Upon the authorization by the Lead Representatives of the release of the Firm Shares, the
several Underwriters propose to offer the Firm Shares for sale upon the terms and conditions set
forth in the Prospectus.
4. (a) The Shares to be purchased by each Underwriter hereunder, in such authorized
denominations and registered in such names as the Lead Representatives may request upon at least
forty-eight hours’ prior notice to the Company, shall be delivered by or on behalf of the Company
to the account specified by the Lead Representatives, through the facilities of The Depository
Trust Company (“DTC”), for the account of such Underwriter, against payment by or on behalf of such
Underwriter of the purchase price therefor by wire transfer of Federal (same-day) funds to the
account specified by the Company to the Lead Representatives at least forty-eight hours in advance.
The time and date of such delivery and payment shall be, with respect to the Firm Shares, 9:30
a.m., New York City time, on [___], 2007 or such other time and date as the Lead
Representatives and the Company may agree upon in writing, and, with respect to the Optional
Shares, 9:30 a.m., New York time, on the date specified by the Lead Representatives in the written
notice given by the Lead Representatives of the Underwriters’ election to purchase such Optional
Shares, or such other time and date as the Lead Representatives and the Company may agree upon in
writing. Such time and date for delivery of the Firm Shares is herein called the “First Time of
Delivery”, such time and date for delivery of the Optional Shares, if not the First Time of
Delivery, is herein called the “Second Time of Delivery”, and each such time and date for delivery
is herein called a “Time of Delivery”.
12
(b) The documents to be delivered at each Time of Delivery by or on behalf of the parties
hereto pursuant to Section 8 hereof, including the cross receipt for the Shares and any additional
documents requested by the Underwriters pursuant to Section 8[(k)] hereof, will be delivered at the
offices of Xxxxxxx Xxxxxxx & Xxxxxxxx LLP, 000 Xxxxxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000 (the
“Closing Location”), and the Shares will be delivered through the facilities of DTC, all at such
Time of Delivery. A meeting will be held at the Closing Location at [___] p.m., New York City
time, on the New York Business Day next preceding such Time of Delivery, at which meeting the final
drafts of the documents to be delivered pursuant to the preceding sentence will be available for
review by the parties hereto. For the purposes of this Section 4, “New York Business Day” shall
mean each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking
institutions in New York City are generally authorized or obligated by law or executive order to
close.
5. The Company and, in respect of Section 5(e) hereof, the Partnerships agree with each of the
Underwriters:
(a) To prepare the Prospectus in a form approved by you and to file such Prospectus pursuant
to Rule 424(b) under the Act not later than the Commission’s close of business on the second
business day following the execution and delivery of this Agreement, or, if applicable, such
earlier time as may be required by Rule 430A(a)(3) under the Act; to make no further amendment or
any supplement to the Registration Statement or the Prospectus prior to the last Time of Delivery
without your consent, which shall not be unreasonably withheld; to advise you, promptly after it
receives notice thereof, of the time when any amendment to the Registration Statement has been
filed or becomes effective or any amendment or supplement to the Prospectus has been filed and to
furnish you with copies thereof; to file promptly all material required to be filed by the Company
with the Commission pursuant to Rule 433(d) under the Act; to advise you, promptly after it
receives notice thereof, of the issuance by the Commission of any stop order or of any order
preventing or suspending the use of any Preliminary Prospectus or other prospectus in respect of
the Shares, of the suspension of the qualification of the Shares for offering or sale in any
jurisdiction, of the initiation or threatening of any proceeding for any such purpose, or of any
request by the Commission for the amending or supplementing of the Registration Statement or the
Prospectus or for additional information; and, in the event of the issuance of any stop order or of
any order preventing or suspending the use of any Preliminary Prospectus or other prospectus or
suspending any such qualification, to promptly use its best efforts to obtain the withdrawal of
such order;
(b) Promptly from time to time to take such action as you may reasonably request to qualify
the Shares for offering and sale under the securities laws of such jurisdictions as you may request
and to comply with such laws so as to permit the continuance of sales and dealings therein in such
jurisdictions for as long as may be necessary to complete the distribution of the Shares, provided
13
that in connection therewith the Company shall not be required to qualify as a foreign
corporation or as a dealer in securities, to file a general consent to service of process in any
jurisdiction or to subject itself to taxation in any jurisdiction if it is not otherwise so
subject;
(c) Prior to 10:00 a.m., New York City time, on the second New York Business Day following the
date of this Agreement and from time to time, to furnish the Underwriters with written and
electronic copies of the Prospectus in New York City in such quantities as you may reasonably
request, and, if the delivery of a prospectus (or in lieu thereof, the notice referred to in Rule
173(a) under the Act) is required at any time prior to the expiration of nine months after the time
of issue of the Prospectus in connection with the offering or sale of the Shares and if at such
time any event shall have occurred as a result of which the Prospectus as then amended or
supplemented would include an untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements therein, in the light of the circumstances under
which they were made when such Prospectus (or in lieu thereof, the notice referred to in Rule
173(a) under the Act) is delivered, not misleading, or, if for any other reason it shall be
necessary during such same period to amend or supplement the Prospectus in order to comply with the
Act, to notify you and upon your request to prepare and furnish without charge to each Underwriter
and to any dealer in securities as many written and electronic copies as you may from time to time
reasonably request of an amended Prospectus or a supplement to the Prospectus which will correct
such statement or omission or effect such compliance; and in case any Underwriter is required to
deliver a prospectus (or in lieu thereof, the notice referred to in Rule 173(a) under the Act) in
connection with sales of any of the Shares at any time nine months or more after the time of issue
of the Prospectus, upon your request but at the expense of such Underwriter, to prepare and deliver
to such Underwriter as many written and electronic copies as you may request of an amended or
supplemented Prospectus complying with Section 10(a)(3) of the Act;
(d) To make generally available to its securityholders as soon as practicable, but in any
event not later than sixteen months after the effective date of the Registration Statement (as
defined in Rule 158(c) under the Act), an earnings statement of the Company and its subsidiaries
(which need not be audited) complying with Section 11(a) of the Act and the rules and regulations
of the Commission thereunder (including, at the option of the Company, Rule 158);
(e) During the period beginning from the date hereof and continuing to and including the date
180 days after the date of the Prospectus (the “Lock-Up Period”), not to offer, sell, contract to
sell, pledge, grant any option to purchase, make any short sale or otherwise dispose, or to permit
any of their respective subsidiaries to offer, sell, contract to sell, pledge, grant any option to
purchase, make any short sale or otherwise dispose, except as provided hereunder, of any securities
of the Company, the Partnerships or any of their subsidiaries that are
14
substantially similar to the Shares, including but not limited to any options or warrants to
purchase shares of Stock or any securities that are convertible into or exchangeable for, or that
represent the right to receive, Stock or any such substantially similar securities without your
prior written consent (other than (i) the issuance and sale of the Shares as contemplated by this
Agreement; (ii) pursuant to employee or director compensation, benefit, stock option or stock
purchase plans existing on, or upon the conversion or exchange of convertible or exchangeable
securities outstanding as of, the date of this Agreement; and
(iii) up to an aggregate of [____]
shares of Stock or securities convertible into or exercisable or exchangeable for Stock issued in
connection with any acquisition of assets or acquisition of a majority or controlling portion of
the equity of another entity, provided, however, that any recipient of Stock or
securities convertible into or exercisable or exchangeable for Stock pursuant to this clause (iii)
executes and delivers to the Lead Representatives a “lock-up” agreement covering such Stock or
securities for the remainder of the 180-day restricted period or any extension thereof as described
below); provided, however, that if (1) during the last 17 days of the initial
Lock-Up Period, the Company releases earnings results or announces material news or a material
event or (2) prior to the expiration of the initial Lock-Up Period, the Company announces that it
will release earnings results during the 15-day period following the last day of the initial
Lock-Up Period, then in each case the Lock-Up Period will be automatically extended until the
expiration of the 18-day period beginning on the date of release of the earnings results or the
announcement of the material news or material event, as applicable, unless the Lead Representatives
waive, in writing, such extension; the Company will provide the Lead Representatives and each
stockholder subject to the Lock-Up Period pursuant to the lockup letters described in Section
8[(i)] with prior notice of any such announcement that gives rise to an extension of the Lock-up
Period;
(f) To furnish to its stockholders as soon as practicable after the end of each fiscal year an
annual report (including a balance sheet and statements of income, stockholders’ equity and cash
flows of the Company and its consolidated subsidiaries certified by independent public accountants)
and, as soon as practicable after the end of each of the first three quarters of each fiscal year
(beginning with the fiscal quarter ending after the effective date of the Registration Statement),
to make available to its stockholders consolidated summary financial information of the Company and
its subsidiaries for such quarter in reasonable detail; provided that any report or
financial statement furnished or filed with the Commission that is publicly available on the
Commission’s XXXXX system shall be deemed to have been furnished to the stockholders at the time
furnished or filed with the Commission;
(g) During a period of two years from the effective date of the Registration Statement, to
furnish to you copies of all reports or other communications (financial or other) furnished to
stockholders, and to deliver to
15
you (i) as soon as they are available, copies of any reports and financial statements
furnished to or filed with the Commission or any national securities exchange on which any class of
securities of the Company is listed; and (ii) such additional information concerning the business
and financial condition of the Company as you may from time to time reasonably request (such
financial statements to be on a consolidated basis to the extent the accounts of the Company and
its subsidiaries are consolidated in reports furnished to its stockholders generally or to the
Commission); provided that any report, communication or financial statement furnished or
filed with the Commission that is publicly available on the Commission’s XXXXX system shall be
deemed to have been furnished to you at the time furnished or filed with the Commission;
(h) To use the net proceeds received by it from the sale of the Shares pursuant to this
Agreement in the manner specified in the Pricing Prospectus under the caption “Use of Proceeds”;
(i) To use its best efforts to list, subject to notice of issuance, the Shares on the
Exchange;
(j) To file with the Commission such information on Form 10-Q or Form 10-K as may be required
by Rule 463 under the Act;
(k) If the Company elects to rely upon Rule 462(b), the Company shall file a Rule 462(b)
Registration Statement with the Commission in compliance with Rule 462(b) by 10:00 P.M.,
Washington, D.C. time, on the date of this Agreement, and the Company shall at the time of filing
either pay to the Commission the filing fee for the Rule 462(b) Registration Statement or give
irrevocable instructions for the payment of such fee pursuant to Rule 111(b) under the Act;
(l) Upon request of any Underwriter, to furnish, or cause to be furnished, to such Underwriter
an electronic version of the Company’s trademarks, servicemarks and corporate logo for use on the
website, if any, operated by such Underwriter for the purpose of facilitating the on-line offering
of the Shares (the “License”); provided, however, that the License shall be used
solely for the purpose described above, is granted without any fee and may not be assigned or
transferred; and
(m) To comply with all applicable securities and other laws, rules and regulations in each
jurisdiction in which the Directed Shares are offered in connection with the Directed Share
Program.
6. (a) The Company represents and agrees that, without the prior consent of the Lead
Representatives, it has not made and will not make any offer relating to the Shares that would
constitute a “free writing prospectus” as defined in Rule 405 under the Act; each Underwriter
represents and agrees that, without the prior consent of the Company and the Lead Representatives,
it has not made and will not make any offer relating to the Shares that would constitute a free
writing prospectus; any such free writing prospectus the use of which has been
16
consented to by the Company and the Lead Representatives is listed on Schedule II(a) hereto;
(b) The Company has complied and will comply with the requirements of Rule 433 under the Act
applicable to any Issuer Free Writing Prospectus, including timely filing with the Commission or
retention where required and legending; and the Company represents that it has satisfied and agrees
that it will satisfy the conditions under Rule 433 under the Act to avoid a requirement to file
with the Commission any electronic road show; and
(c) The Company agrees that if at any time following issuance of an Issuer Free Writing
Prospectus any event occurred or occurs as a result of which such Issuer Free Writing Prospectus
would conflict with the information in the Registration Statement, the Pricing Prospectus or the
Prospectus or would include an untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements therein, in the light of the circumstances then
prevailing, not misleading, the Company will give prompt notice thereof to the Lead Representatives
and, if requested by the Lead Representatives, will prepare and furnish without charge to each
Underwriter an Issuer Free Writing Prospectus or other document which will correct such conflict,
statement or omission; provided, however, that this representation and warranty
shall not apply to any statements or omissions in an Issuer Free Writing Prospectus made in
reliance upon and in conformity with information furnished in writing to the Company by an
Underwriter through the Lead Representatives expressly for use therein.
7. The Company and the Partnerships covenant and agree with the several Underwriters that they
will pay or cause to be paid the following: (i) the fees, disbursements and expenses of the
Company’s counsel and accountants in connection with the registration of the Shares under the Act
and all other expenses in connection with the preparation, printing, reproduction and filing of the
Registration Statement, any Preliminary Prospectus, any Issuer Free Writing Prospectus and the
Prospectus and amendments and supplements thereto and the mailing and delivering of copies thereof
to the Underwriters and dealers; (ii) the cost of printing or producing any Agreement among
Underwriters, this Agreement, the Blue Sky Memorandum, closing documents (including any
compilations thereof) and any other documents in connection with the offering, purchase, sale and
delivery of the Shares; (iii) all expenses in connection with the qualification of the Shares for
offering and sale under state securities laws as provided in Section 5(b) hereof, including the
fees and disbursements of counsel for the Underwriters in connection with such qualification and in
connection with the Blue Sky survey (iv) all fees and expenses in connection with listing the
Shares on the Exchange; (v) the filing fees incident to, and the fees and disbursements of counsel
for the Underwriters in connection with, any required review by the National Association of
Securities Dealers, Inc. of the terms of the
17
sale of the Shares; (vi) the cost of preparing stock certificates; (vii) the cost and charges
of any transfer agent or registrar; (viii) all fees and disbursements of counsel incurred by the
Underwriters in connection with the Directed Share Program and stamp duties, similar taxes or
duties or other taxes, if any, incurred by the Underwriters in connection with the Directed Share
Program; and (ix) all other costs and expenses incident to the performance of its obligations
hereunder which are not otherwise specifically provided for in this Section. It is understood,
however, that, except as provided in this Section, and Sections 9, 10 and 13 hereof, the
Underwriters will pay all of their own costs and expenses, including the fees of their counsel,
stock transfer taxes on resale of any of the Shares by them, and any advertising expenses connected
with any offers they may make.
8. The obligations of the Underwriters hereunder, as to the Shares to be delivered at each
Time of Delivery, shall be subject, in their discretion, to the condition that all representations
and warranties and other statements of the Company and the Partnerships herein are, at and as of
such Time of Delivery, true and correct, the condition that the Company and the Partnerships shall
have performed all of their obligations hereunder theretofore to be performed, and the following
additional conditions:
(a) The Prospectus shall have been filed with the Commission pursuant to Rule 424(b)
under the Act within the applicable time period prescribed for such filing by the rules and
regulations under the Act and in accordance with Section 5(a) hereof; all material required
to be filed by the Company pursuant to Rule 433(d) under the Act shall have been filed with
the Commission within the applicable time period prescribed for such filing by Rule 433; if
the Company has elected to rely upon Rule 462(b) under the Act, the Rule 462(b)
Registration Statement shall have become effective by 10:00 P.M., Washington, D.C. time, on
the date of this Agreement; no stop order suspending the effectiveness of the Registration
Statement or any part thereof shall have been issued and no proceeding for that purpose
shall have been initiated or threatened by the Commission; no stop order suspending or
preventing the use of the Prospectus or any Issuer Free Writing Prospectus shall have been
initiated or threatened by the Commission; and all requests for additional information on
the part of the Commission shall have been complied with to your reasonable satisfaction;
(b) Xxxxxxx Xxxxxxx & Xxxxxxxx LLP, counsel for the Underwriters, shall have furnished
to you such written opinion or opinions with respect to such matters as you may reasonably
request, and such counsel shall have received such papers and information as they may
reasonably request to enable them to pass upon such matters;
18
(c) Dechert LLP, counsel for the Company, shall have furnished to you their written
opinion, in form and substance satisfactory to you, substantially to the effect set forth
in Annex II(b) hereto and dated such Time of Delivery;
(d) On the date of the Prospectus at a time prior to the execution of this Agreement,
at 9:30 a.m., New York City time, on the effective date of any post-effective amendment to
the Registration Statement filed subsequent to the date of this Agreement and also at each
Time of Delivery, Ernst & Young LLP shall have furnished to you a letter or letters, dated
the respective dates of delivery thereof, in form and substance satisfactory to you, to the
effect set forth in Annex I hereto (the executed copy of the letter delivered prior to the
execution of this Agreement is attached as Annex I(a) hereto and a draft of the form of
letter to be delivered on the effective date of any post-effective amendment to the
Registration Statement and as of each Time of Delivery is attached as Annex I(b) hereto);
(e) (i) Neither the Company nor the Partnerships nor any of their respective
subsidiaries shall have sustained since the date of the latest audited financial statements
included in the Pricing Prospectus any loss or interference with its business from fire,
explosion, flood or other calamity, whether or not covered by insurance, or from any labor
dispute or court or governmental action, order or decree, otherwise than as set forth or
contemplated in the Pricing Prospectus, and (ii) since the respective dates as of which
information is given in the Pricing Prospectus, there shall not have been any change in the
capital stock or long-term debt of the Company, the Partnerships or any of their respective
subsidiaries or any change, or any development involving a prospective change, in or
affecting the general affairs, management, financial position, stockholders’ equity or
results of operations of the Company, the Partnerships and their respective subsidiaries,
taken as a whole, otherwise than as set forth or contemplated in the Pricing Prospectus,
the effect of which, in any such case described in clause (i) or (ii), is in your judgment
so material and adverse as to make it impracticable or inadvisable to proceed with the
public offering or the delivery of the Shares being delivered at such Time of Delivery on
the terms and in the manner contemplated in the Prospectus;
(f) On or after the Applicable Time (i) no downgrading shall have occurred in the
rating accorded the debt securities or preferred stock of the Company, the Partnerships or
their respective subsidiaries by any “nationally recognized statistical rating
organization”, as that term is defined by the Commission for purposes of Rule 436(g)(2)
under the Act, and (ii) no such organization shall have publicly announced that it has
under surveillance or review, with possible negative implications, its rating of any
19
of the debt securities or preferred stock of the Company, the Partnerships or their
respective subsidiaries;
(g) On or after the Applicable Time there shall not have occurred any of the
following: (i) a suspension or material limitation in trading in securities generally on
the Exchange; (ii) a suspension or material limitation in trading in the Company’s
securities on the Exchange; (iii) a general moratorium on commercial banking activities
declared by either Federal or New York State authorities or a material disruption in
commercial banking or securities settlement or clearance services in the United States;
(iv) the outbreak or escalation of hostilities involving the United States or the
declaration by the United States of a national emergency or war; or (v) the occurrence of
any other calamity or crisis or any change in financial, political or economic conditions
in the United States or elsewhere, if the effect of any such event specified in clause (iv)
or (v) in your judgment makes it impracticable or inadvisable to proceed with the public
offering or the delivery of the Shares being delivered at such Time of Delivery on the
terms and in the manner contemplated in the Prospectus;
(h) The Shares to be sold at such Time of Delivery shall have been duly listed,
subject to notice of issuance, on the Exchange;
(i) The Company shall have obtained and delivered to the Underwriters executed copies
of an agreement from each person listed on Schedule III hereto to the effect set forth in
Annex III hereto, in form and substance satisfactory to you;
(j) The Reorganization Transactions shall have been consummated; and
(k) The Company and the Partnerships shall have furnished or caused to be furnished to
you at such Time of Delivery certificates of officers of the Company or the Partnerships,
as the case may be, satisfactory to you as to the accuracy of the representations and
warranties of the Company and the Partnerships herein at and as of such Time of Delivery,
as to the performance by the Company and the Partnerships of all of their obligations
hereunder to be performed at or prior to such Time of Delivery, as to the matters set forth
in subsections (a) and (e) of this Section and as to such other matters as you may
reasonably request.
9. (a) The Company and the Partnerships will jointly and severally indemnify and hold
harmless each Underwriter against any losses, claims, damages or liabilities, joint or several, to
which such Underwriter may become subject, under the Act or otherwise, insofar as such losses,
claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an
untrue statement or alleged untrue statement of a material fact contained in the
20
Registration Statement, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus,
or any amendment or supplement thereto, any Issuer Free Writing Prospectus or any “issuer
information” filed or required to be filed pursuant to Rule 433(d) under the Act, or arise out of
or are based upon the omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading, and will reimburse each
Underwriter for any legal or other expenses reasonably incurred by such Underwriter in connection
with investigating or defending any such action or claim as such expenses are incurred;
provided, however, that the Company and the Partnerships shall not be liable in any
such case to the extent that any such loss, claim, damage or liability arises out of or is based
upon an untrue statement or alleged untrue statement or omission or alleged omission made in the
Registration Statement, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or
any amendment or supplement thereto, or any Issuer Free Writing Prospectus, in reliance upon and in
conformity with written information furnished to the Company by any Underwriter through the Lead
Representatives expressly for use therein.
(b) Each Underwriter will indemnify and hold harmless the Company against any losses, claims,
damages or liabilities to which the Company may become subject, under the Act or otherwise, insofar
as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are
based upon an untrue statement or alleged untrue statement of a material fact contained in the
Registration Statement, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or
any amendment or supplement thereto, or any Issuer Free Writing Prospectus, or arise out of or are
based upon the omission or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading, in each case to the extent, but
only to the extent, that such untrue statement or alleged untrue statement or omission or alleged
omission was made in the Registration Statement, any Preliminary Prospectus, the Pricing Prospectus
or the Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus,
in reliance upon and in conformity with written information furnished to the Company by such
Underwriter through the Lead Representatives expressly for use therein; and will reimburse the
Company for any legal or other expenses reasonably incurred by the Company in connection with
investigating or defending any such action or claim as such expenses are incurred.
(c) Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice
of the commencement of any action, such indemnified party shall, if a claim in respect thereof is
to be made against the indemnifying party under such subsection, notify the indemnifying party in
writing of the commencement thereof; but the omission so to notify the indemnifying party shall not
relieve the indemnifying party from any liability which it may have to any indemnified party
otherwise than under such subsection. In case any such action
21
shall be brought against any indemnified party and it shall notify the indemnifying party of
the commencement thereof, the indemnifying party shall be entitled to participate therein and, to
the extent that it shall wish, jointly with any other indemnifying party similarly notified, to
assume the defense thereof, with counsel reasonably satisfactory to such indemnified party (who
shall not, except with the consent of the indemnified party, be counsel to the indemnifying party),
and, after notice from the indemnifying party to such indemnified party of its election so to
assume the defense thereof, the indemnifying party shall not be liable to such indemnified party
under such subsection for any legal expenses of other counsel or any other expenses, in each case
subsequently incurred by such indemnified party, in connection with the defense thereof other than
reasonable costs of investigation. No indemnifying party shall, without the written consent of the
indemnified party, effect the settlement or compromise of, or consent to the entry of any judgment
with respect to, any pending or threatened action or claim in respect of which indemnification or
contribution may be sought hereunder (whether or not the indemnified party is an actual or
potential party to such action or claim) unless such settlement, compromise or judgment (i)
includes an unconditional release of the indemnified party from all liability arising out of such
action or claim and (ii) does not include a statement as to or an admission of fault, culpability
or a failure to act, by or on behalf of any indemnified party.
(d) If the indemnification provided for in this Section 9 is unavailable or insufficient to
hold harmless an indemnified party under subsection (a) or (b) above in respect of any losses,
claims, damages or liabilities (or actions in respect thereof) referred to therein, then each
indemnifying party shall contribute to the amount paid or payable by such indemnified party as a
result of such losses, claims, damages or liabilities (or actions in respect thereof) in such
proportion as is appropriate to reflect the relative benefits received by the Company and the
Partnerships on the one hand and the Underwriters on the other hand from the offering of the
Shares. If, however, the allocation provided by the immediately preceding sentence is not
permitted by applicable law or if the indemnified party failed to give the notice required under
subsection (c) above, then each indemnifying party shall contribute to such amount paid or payable
by such indemnified party in such proportion as is appropriate to reflect not only such relative
benefits but also the relative fault of the Company and the Partnerships on the one hand and the
Underwriters on the other hand in connection with the statements or omissions which resulted in
such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other
relevant equitable considerations. The relative benefits received by the Company and the
Partnerships on the one hand and the Underwriters on the other hand shall be deemed to be in the
same proportion as the total net proceeds from the offering (before deducting expenses) received by
the Company bear to the total underwriting discounts and commissions received by the Underwriters,
in each case as set forth in the table on the cover page of the Prospectus. The relative
22
fault shall be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company or the Partnerships on the one hand or the
Underwriters on the other hand and the parties’ relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission. The Company and the Partnerships
and the Underwriters agree that it would not be just and equitable if contribution pursuant to this
subsection (d) were determined by pro rata allocation (even if the Underwriters were treated as one
entity for such purpose) or by any other method of allocation which does not take account of the
equitable considerations referred to above in this subsection (d). The amount paid or payable by
an indemnified party as a result of the losses, claims, damages or liabilities (or actions in
respect thereof) referred to above in this subsection (d) shall be deemed to include any legal or
other expenses reasonably incurred by such indemnified party in connection with investigating or
defending any such action or claim. Notwithstanding the provisions of this subsection (d), no
Underwriter shall be required to contribute any amount in excess of the amount by which the total
price at which the Shares underwritten by it and distributed to the public were offered to the
public exceeds the amount of any damages which such Underwriter has otherwise been required to pay
by reason of such untrue or alleged untrue statement or omission or alleged omission. No person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.
The Underwriters’ obligations in this subsection (d) to contribute are several in proportion to
their respective underwriting obligations and not joint.
(e) The obligations of the Company and the Partnerships under this Section 9 shall be in
addition to any liability which the Company and the Partnerships may otherwise have and shall
extend, upon the same terms and conditions, to each person, if any, who controls any Underwriter
within the meaning of the Act and each broker-dealer affiliate of any Underwriter; and the
obligations of the Underwriters under this Section 9 shall be in addition to any liability which
the respective Underwriters may otherwise have and shall extend, upon the same terms and
conditions, to each officer and director of the Company (including any person who, with his or her
consent, is named in the Registration Statement as about to become a director of the Company) and
to each person, if any, who controls the Company within the meaning of the Act.
10. (a) The Company agrees to indemnify and hold harmless Xxxxxx Xxxxxxx, each person, if any,
who controls Xxxxxx Xxxxxxx within the meaning of either Section 15 of the Securities Act or
Section 20 of the Exchange Act and each affiliate of Xxxxxx Xxxxxxx within the meaning of Rule 405
of the Securities Act (“Xxxxxx Xxxxxxx Entities”) from and against any and all losses, claims,
damages and liabilities (including, without limitation, any legal or other expenses
23
reasonably incurred in connection with defending or investigating any such action or claim)
(i) caused by any untrue statement or alleged untrue statement of a material fact contained in any
material prepared by or with the consent of the Company for distribution to Participants in
connection with the Directed Share Program or caused by any omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the statements therein
not misleading; (ii) caused by the failure of any Participant to pay for and accept delivery of
Directed Shares that the Participant agreed to purchase; or (iii) related to, arising out of, or in
connection with the Directed Share Program, other than losses, claims, damages or liabilities (or
expenses relating thereto) that are finally judicially determined to have resulted from the bad
faith or gross negligence of Xxxxxx Xxxxxxx Entities.
(b) In case any proceeding (including any governmental investigation) shall be instituted
involving any Xxxxxx Xxxxxxx Entity in respect of which indemnity may be sought pursuant to Section
10(a), the Xxxxxx Xxxxxxx Entity seeking indemnity, shall promptly notify the Company in writing
and the Company, upon request of the Xxxxxx Xxxxxxx Entity, shall retain counsel reasonably
satisfactory to the Xxxxxx Xxxxxxx Entity to represent the Xxxxxx Xxxxxxx Entity and any others the
Company may designate in such proceeding and shall pay the fees and disbursements of such counsel
related to such proceeding. In any such proceeding, any Xxxxxx Xxxxxxx Entity shall have the right
to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of
such Xxxxxx Xxxxxxx Entity unless (i) the Company shall have agreed to the retention of such
counsel or (ii) the named parties to any such proceeding (including any impleaded parties) include
both the Company and the Xxxxxx Xxxxxxx Entity and representation of both parties by the same
counsel would be inappropriate due to actual or potential differing interests between them. The
Company shall not, in respect of the legal expenses of the Xxxxxx Xxxxxxx Entities in connection
with any proceeding or related proceedings in the same jurisdiction, be liable for the fees and
expenses of more than one separate firm (in addition to any local counsel) for all Xxxxxx Xxxxxxx
Entities. Any such separate firm for the Xxxxxx Xxxxxxx Entities shall be designated in writing by
Xxxxxx Xxxxxxx. The Company shall not be liable for any settlement of any proceeding effected
without its written consent, but if settled with such consent or if there be a final judgment for
the plaintiff, the Company agrees to indemnify the Xxxxxx Xxxxxxx Entities from and against any
loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing
sentence, if at any time a Xxxxxx Xxxxxxx Entity shall have requested the Company to reimburse it
for fees and expenses of counsel as contemplated by the second and third sentences of this
paragraph, the Company agrees that it shall be liable for any settlement of any proceeding effected
without its written consent if (i) such settlement is entered into more than 30 days after receipt
by the Company of the aforesaid request and (ii) the Company shall not have reimbursed the Xxxxxx
Xxxxxxx Entity in accordance
24
with such request prior to the date of such settlement. The Company shall not, without the
prior written consent of Xxxxxx Xxxxxxx, effect any settlement of any pending or threatened
proceeding in respect of which any Xxxxxx Xxxxxxx Entity is or could have been a party and
indemnity could have been sought hereunder by such Xxxxxx Xxxxxxx Entity, unless such settlement
includes an unconditional release of the Xxxxxx Xxxxxxx Entities from all liability on claims that
are the subject matter of such proceeding.
(c) To the extent the indemnification provided for in Section 10(a) is unavailable to a Xxxxxx
Xxxxxxx Entity or insufficient in respect of any losses, claims, damages or liabilities referred to
therein, then the Company in lieu of indemnifying the Xxxxxx Xxxxxxx Entity thereunder, shall
contribute to the amount paid or payable by the Xxxxxx Xxxxxxx Entity as a result of such losses,
claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative
benefits received by the Company on the one hand and the Xxxxxx Xxxxxxx Entities on the other hand
from the offering of the Directed Shares or (ii) if the allocation provided by clause 10(c)(i)
above is not permitted by applicable law, in such proportion as is appropriate to reflect not only
the relative benefits referred to in clause 10(c)(i) above but also the relative fault of the
Company on the one hand and of the Xxxxxx Xxxxxxx Entities on the other hand in connection with any
statements or omissions that resulted in such losses, claims, damages or liabilities, as well as
any other relevant equitable considerations. The relative benefits received by the Company on the
one hand and the Xxxxxx Xxxxxxx Entities on the other hand in connection with the offering of the
Directed Shares shall be deemed to be in the same respective proportions as the net proceeds from
the offering of the Directed Shares (before deducting expenses) and the total underwriting
discounts and commissions received by the Xxxxxx Xxxxxxx Entities for the Directed Shares, bear to
the aggregate Public Offering Price of the Directed Shares. If the loss, claim, damage or
liability is caused by an untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact, the relative fault of the Company on the one hand and
the Xxxxxx Xxxxxxx Entities on the other hand shall be determined by reference to, among other
things, whether the untrue or alleged untrue statement or the omission or alleged omission relates
to information supplied by the Company or by the Xxxxxx Xxxxxxx Entities and the parties’ relative
intent, knowledge, access to information and opportunity to correct or prevent such statement or
omission.
(d) The Company and the Xxxxxx Xxxxxxx Entities agree that it would not be just or equitable
if contribution pursuant to this Section 10 were determined by pro rata allocation (even if the
Xxxxxx Xxxxxxx Entities were treated as one entity for such purpose) or by any other method of
allocation that does not take account of the equitable considerations referred to in Section 10(c).
The amount paid or payable by the Xxxxxx Xxxxxxx Entities as a result of the losses, claims,
damages and liabilities referred to in the immediately preceding paragraph shall be deemed to
include, subject to the limitations set forth above, any legal or other expenses
25
reasonably incurred by the Xxxxxx Xxxxxxx Entities in connection with investigating or
defending any such action or claim. Notwithstanding the provisions of this Section 10, no Xxxxxx
Xxxxxxx Entity shall be required to contribute any amount in excess of the amount by which the
total price at which the Directed Shares distributed to the public were offered to the public
exceeds the amount of any damages that such Xxxxxx Xxxxxxx Entity has otherwise been required to
pay. The remedies provided for in this Section 10 are not exclusive and shall not limit any rights
or remedies which may otherwise be available to any indemnified party at law or in equity.
(e) The indemnity and contribution provisions contained in this Section 10 shall remain
operative and in full force and effect regardless of (i) any termination of this Agreement, (ii)
any investigation made by or on behalf of any Xxxxxx Xxxxxxx Entity or the Company, its officers or
directors or any person controlling the Company and (iii) acceptance of and payment for any of the
Directed Shares.
11. (a) If any Underwriter shall default in its obligation to purchase the Shares which it has
agreed to purchase hereunder at a Time of Delivery, you may in your discretion arrange for you or
another party or other parties to purchase such Shares on the terms contained herein. If within
thirty-six hours after such default by any Underwriter you do not arrange for the purchase of such
Shares, then the Company shall be entitled to a further period of thirty-six hours within which to
procure another party or other parties satisfactory to you to purchase such Shares on such terms.
In the event that, within the respective prescribed periods, you notify the Company that you have
so arranged for the purchase of such Shares, or the Company notifies you that it has so arranged
for the purchase of such Shares, you or the Company shall have the right to postpone such Time of
Delivery for a period of not more than seven days, in order to effect whatever changes that in the
opinion of your counsel may thereby be made necessary in the Registration Statement or the
Prospectus, or in any other documents or arrangements, and the Company agrees to file promptly any
amendments or supplements to the Registration Statement or the Prospectus which in the opinion of
your counsel may thereby be made necessary. The term “Underwriter” as used in this Agreement shall
include any person substituted under this Section with like effect as if such person had originally
been a party to this Agreement with respect to such Shares.
(b) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting
Underwriter or Underwriters by you and the Company as provided in subsection (a) above, the
aggregate number of such Shares which remains unpurchased does not exceed one-eleventh of the
aggregate number of all the Shares to be purchased at such Time of Delivery, then the Company shall
have the right to require each non-defaulting Underwriter to purchase the number of shares which
such Underwriter agreed to purchase hereunder at such Time of Delivery and, in addition, to require
each non-defaulting Underwriter to purchase its pro rata share (based on the number of Shares which
such Underwriter agreed
26
to purchase hereunder) of the Shares of such defaulting Underwriter or Underwriters for which
such arrangements have not been made; but nothing herein shall relieve a defaulting Underwriter
from liability for its default.
(c) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting
Underwriter or Underwriters by you and the Company as provided in subsection (a) above, the
aggregate number of such Shares which remains unpurchased exceeds one-eleventh of the aggregate
number of all the Shares to be purchased at such Time of Delivery, or if the Company shall not
exercise the right described in subsection (b) above to require non-defaulting Underwriters to
purchase Shares of a defaulting Underwriter or Underwriters, then this Agreement (or, with respect
to the Second Time of Delivery, the obligations of the Underwriters to purchase and of the Company
to sell the Optional Shares) shall thereupon terminate, without liability on the part of any
non-defaulting Underwriter, the Company or the Partnerships, except for the expenses to be borne by
the Company, the Partnerships and the Underwriters as provided in Section 7 hereof and the
indemnity and contribution agreements in Section 9 hereof; but nothing herein shall relieve a
defaulting Underwriter from liability for its default.
12. The respective indemnities, agreements, representations, warranties and other statements
of the Company and the several Underwriters, as set forth in this Agreement or made by or on behalf
of them, respectively, pursuant to this Agreement, shall remain in full force and effect,
regardless of any investigation (or any statement as to the results thereof) made by or on behalf
of any Underwriter or any controlling person of any Underwriter, or the Company, or any officer or
director or controlling person of the Company, and shall survive delivery of and payment for the
Shares.
13. If this Agreement shall be terminated pursuant to Section 11 hereof or in connection with
the occurrence of any event specified in clauses (i), (iii), (iv) or (v) of Section 8(g) hereof,
the Company and the Partnerships shall not then be under any liability to any Underwriter except as
provided in Sections 7 and 9 hereof; but, if for any other reason, any Shares are not delivered by
or on behalf of the Company as provided herein, the Company and the Partnerships will reimburse the
Underwriters through you for all out-of-pocket expenses approved in writing by you, including fees
and disbursements of counsel, reasonably incurred by the Underwriters in making preparations for
the purchase, sale and delivery of the Shares not so delivered, but the Company and the
Partnerships shall then be under no further liability to any Underwriter except as provided in
Sections 7 and 9 hereof.
14. In all dealings hereunder, you shall act on behalf of each of the Underwriters, and the
parties hereto shall be entitled to act and rely upon any statement, request, notice or agreement
on behalf of any Underwriter made or given by you jointly or by any Lead Representative on behalf
of you as the
27
representatives. All statements, requests, notices and agreements hereunder shall be in
writing, and if to the Underwriters shall be delivered or sent by mail, telex or facsimile
transmission to you as the Lead Representatives in care of Xxxxxxx, Sachs & Co., Xxx Xxx Xxxx
Xxxxx, 00xx Xxxxx, Xxx Xxxx, Xxx Xxxx 00000, Attention: Registration Department, and in
care of Xxxxxx Xxxxxxx & Co. Incorporated, 0000 Xxxxxxxx, Xxx Xxxx, Xxx Xxxx 00000, Attention:
Equity Syndicate Desk, with a copy to Xxxxxx Xxxxxxx & Co. Incorporated, 0000 Xxxxxxxx, Xxx Xxxx,
Xxx Xxxx 00000, Attention: Legal Department; and if to the Company or the Partnerships shall be
delivered or sent by mail, telex or facsimile transmission to the address of the Company set forth
in the Registration Statement, Attention: Secretary, with a copy to Dechert LLP, Xxxx Centre, 0000
Xxxx Xxxxxx, Xxxxxxxxxxxx, XX 00000, Attention: Xxxxx X. Xxxxxxxx, Esq. and Xxxxx X. Short, Esq.;
provided, however, that any notice to an Underwriter pursuant to Section 9(c)
hereof shall be delivered or sent by mail, telex or facsimile transmission to such Underwriter at
its address set forth in its Underwriters’ Questionnaire, or telex constituting such Questionnaire,
which address will be supplied to the Company by you upon request; provided,
however, that notices under subsection 5(e) shall be in writing, and if to the Underwriters
shall be delivered or sent by mail, telex or facsimile transmission to you as the Lead
Representatives at Xxxxxxx, Sachs & Co., 00 Xxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000, Attention:
Control Room and Xxxxxx Xxxxxxx & Co. Incorporated, 0000 Xxxxxxxx, Xxx Xxxx, Xxx Xxxx 00000,
Attention: Equity Syndicate Desk, with a copy to Xxxxxx Xxxxxxx & Co. Incorporated, 0000 Xxxxxxxx,
Xxx Xxxx, Xxx Xxxx 00000, Attention: Legal Department. Any such statements, requests, notices or
agreements shall take effect upon receipt thereof.
15. This Agreement shall be binding upon, and inure solely to the benefit of, the
Underwriters, the Company, the Partnerships and, to the extent provided in Sections 9 and 12
hereof, the officers and directors of the Company and each person who controls the Company or any
Underwriter, and their respective heirs, executors, administrators, successors and assigns, and no
other person shall acquire or have any right under or by virtue of this Agreement. No purchaser of
any of the Shares from any Underwriter shall be deemed a successor or assign by reason merely of
such purchase.
16. Time shall be of the essence of this Agreement. As used herein, the term “business day”
shall mean any day when the Commission’s office in Washington, D.C. is open for business.
17. Each of the Company and the Partnerships acknowledges and agrees that (i) the purchase and
sale of the Shares pursuant to this Agreement is an arm’s-length commercial transaction between the
Company, on the one hand, and the several Underwriters, on the other hand, (ii) in connection
therewith and with the process leading to such transaction each Underwriter is acting solely as a
principal and not the agent or fiduciary of the Company or the Partnerships, (iii) no Underwriter
has assumed an advisory or fiduciary responsibility in favor of the
28
Company or the Partnerships with respect to the offering contemplated hereby or the process
leading thereto (irrespective of whether such Underwriter has advised or is currently advising the
Company or the Partnerships on other matters) or any other obligation to the Company or the
Partnerships except the obligations expressly set forth in this Agreement and (iv) each of the
Company and the Partnerships has consulted its own legal and financial advisors to the extent it
deemed appropriate. Each of the Company and the Partnerships agrees that it will not claim that
the Underwriters, or any of them, has rendered advisory services of any nature or respect, or owes
a fiduciary or similar duty to the Company or the Partnerships, in connection with such transaction
or the process leading thereto.
18. This Agreement supersedes all prior agreements and understandings (whether written or
oral) between the Company or the Partnerships and the Underwriters, or any of them, with respect to
the subject matter hereof.
19. This Agreement shall be governed by and construed in accordance with the laws of the State
of New York.
20. The Company, the Partnerships and each of the Underwriters hereby irrevocably waive, to
the fullest extent permitted by applicable law, any and all right to trial by jury in any legal
proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.
21. This Agreement may be executed by any one or more of the parties hereto in any number of
counterparts, each of which shall be deemed to be an original, but all such counterparts shall
together constitute one and the same instrument.
22. Notwithstanding anything herein to the contrary, the Company and the Partnerships are
authorized to disclose to any persons the U.S. federal and state income tax treatment and tax
structure of the potential transaction and all materials of any kind (including tax opinions and
other tax analyses) provided to the Company or the Partnerships relating to that treatment and
structure, without the Underwriters imposing any limitation of any kind. However, any information
relating to the tax treatment and tax structure shall remain confidential (and the foregoing
sentence shall not apply) to the extent necessary to enable any person to comply with securities
laws. For this purpose, “tax structure” is limited to any facts that may be relevant to that
treatment.
If the foregoing is in accordance with your understanding, please sign and return to us five
counterparts hereof, and upon the acceptance hereof by you, on behalf of each of the Underwriters,
this letter and such acceptance hereof shall constitute a binding agreement between each of the
Underwriters and the Company and the Partnerships. It is understood that your acceptance of this
letter on behalf of each of the Underwriters is pursuant to the authority set forth in a form of
Agreement among Underwriters, the form of which shall be submitted to
29
the Company for examination upon request, but without warranty on your part as to the
authority of the signers thereof.
Very truly yours, HFF, Inc. |
||||
By: | ||||
Name: | ||||
Title: | ||||
Xxxxxxxx Xxxxxxxx Xxxxxx, X.X.,
by Xxxxxxxx XX Corp., its
General Partner
|
||||
By: | ||||
Name: | ||||
Title: | ||||
HFF Securities, L.P.
by Xxxxxxxx XX Corp., its
General Partner
|
||||
By: | ||||
Name: | ||||
Title: | ||||
30
Accepted as of the date hereof:
Xxxxxxx, Xxxxx & Co.
Xxxxxx Xxxxxxx & Co. Incorporated
Xxxxxx Xxxxxxx & Co. Incorporated
By: |
||||
By: |
||||
(Xxxxxx Xxxxxxx & Co. Incorporated) |
On behalf of each of the Underwriters
31
SCHEDULE I
Number of | ||||||||
Total | Optional | |||||||
Number of | Shares to be | |||||||
Firm | Purchased if | |||||||
Shares | Maximum | |||||||
to be | Option | |||||||
Underwriter | Purchased | Exercised | ||||||
Xxxxxxx, Sachs & Co. |
||||||||
Xxxxxx Xxxxxxx & Co. Incorporated |
||||||||
[Names of other Underwriters] |
||||||||
Total |
||||||||
32
SCHEDULE II
(a) Issuer Free Writing Prospectuses:
(b) Additional Documents Incorporated by Reference:
SCHEDULE III
HFF Holdings, LLC
Xxxx X. Xxxxxx
Xxxx X. Xxxxxx
Xxxxxx X. Xxxxx, Xx.
Xxxx X. Xxxxxx, Xx.
Xxx X. Xxxxxxxx, Xx.
Xxxxxxx X. Xxxxxx
Xxxxx X. Xxxxxxx
[each director and officer of HFF Inc.]
Xxxx X. Xxxxxx
Xxxx X. Xxxxxx
Xxxxxx X. Xxxxx, Xx.
Xxxx X. Xxxxxx, Xx.
Xxx X. Xxxxxxxx, Xx.
Xxxxxxx X. Xxxxxx
Xxxxx X. Xxxxxxx
[each director and officer of HFF Inc.]
2
ANNEX III
[Form of lock-up agreement]
Lock-Up Agreement
[_______], 2007
Xxxxxxx, Sachs & Co.
Xxxxxx Xxxxxxx & Co. Incorporated
As representatives of the several Underwriters
named in Schedule I hereto,
c/o Goldman, Sachs & Co.
00 Xxxxx Xxxxxx,
Xxx Xxxx, Xxx Xxxx 00000
and
Xxxxxx Xxxxxxx & Co. Incorporated,
0000 Xxxxxxxx,
Xxx Xxxx, Xxx Xxxx 00000
Xxxxxx Xxxxxxx & Co. Incorporated
As representatives of the several Underwriters
named in Schedule I hereto,
c/o Goldman, Sachs & Co.
00 Xxxxx Xxxxxx,
Xxx Xxxx, Xxx Xxxx 00000
and
Xxxxxx Xxxxxxx & Co. Incorporated,
0000 Xxxxxxxx,
Xxx Xxxx, Xxx Xxxx 00000
Re:
HFF, Inc. - Lock-Up Agreement
Ladies and Gentlemen:
The undersigned understands that you, as representatives (the “Representatives”), propose to
enter into an Underwriting Agreement (the “Underwriting Agreement”) on behalf of the several
Underwriters named in Schedule I to the Underwriting Agreement (collectively, the “Underwriters”),
with HFF, Inc., a Delaware corporation (the “Company”), Xxxxxxxx Xxxxxxxx Xxxxxx, X.X., a Texas
limited partnership (“Xxxxxxxx Xxxxxxxx Xxxxxx”) and HFF Securities L.P., a Delaware limited
partnership (“HFF Securities” and, together with Xxxxxxxx Xxxxxxxx Xxxxxx, the “Partnerships”),
providing for a public offering of the Class A Common Stock, par value $0.01 per share of the
Company (the “Shares”) pursuant to a Registration Statement on Form S-1 to be filed with the
Securities and Exchange Commission (the “SEC”).
In consideration of the agreement by the Underwriters to offer and sell the Shares, and of
other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged,
the undersigned agrees that, during the period specified in the following paragraph (the “Lock-Up
Period”), the undersigned will not offer, sell, contract to sell, pledge, grant any option to
purchase, make any short sale or otherwise dispose of any shares of Class A Common Stock of the
Company, or any options or warrants to purchase any shares of Class A Common Stock of the Company,
or any securities convertible into, exchangeable for or that represent the right to receive shares
of Class A Common Stock of the Company or any such substantially similar securities, whether now
owned or hereinafter acquired, owned directly by the undersigned (including holding as a custodian)
or with respect to which the undersigned has beneficial ownership within the rules and regulations
of the SEC (collectively the “Undersigned’s Shares”). The foregoing restriction is expressly agreed
to preclude the undersigned from engaging in any hedging or other transaction which is designed to
or which reasonably could be expected to lead to or result in a sale or disposition of the
Undersigned’s Shares even if such Shares would be disposed of by someone other than the
undersigned. Such prohibited hedging or other transactions would include without limitation any
short sale or any purchase, sale or grant of any right (including without limitation any put or
call option) with respect to any of the Undersigned’s Shares or with respect to any security that
includes, relates to, or derives any significant part of its value from such Shares.
The initial Lock-Up Period will commence on the date of this Lock-Up Agreement and continue
for 180 days after the public offering date set forth on the final prospectus used to sell the
Shares (the “Public Offering Date”) pursuant to the Underwriting Agreement; provided, however, that
if (1) during the last 17 days of the initial Lock-Up Period, any of the Company, the Partnerships
or any of their respective subsidiaries releases earnings results or announces material news or a
material event or (2) prior to the expiration of the initial Lock-Up Period, any of the Company,
the Partnerships or any of their respective subsidiaries announces that it will release earnings
results during the 15-day period following the last day of the initial Lock-Up Period, then in each
case the Lock-Up Period will be automatically extended until the expiration of the 18-day period
beginning on the date of release of the earnings results or the announcement of the material news
or material event, as applicable, unless the Representatives waive, in writing, such extension.
The undersigned hereby acknowledges that the Company and the Partnerships have agreed in the
Underwriting Agreement to provide written notice of any event that would result in an extension of
the Lock-Up Period pursuant to the previous paragraph to the undersigned (in accordance with
Section 14 of the Underwriting Agreement) and agrees that any such notice properly delivered will
be deemed to have been given to, and received by, the undersigned. The undersigned hereby further
agrees that, prior to engaging in any transaction or taking any other action that is subject to the
terms of this Lock-Up Agreement during the period from the date of this Lock-Up Agreement to and
including the 34th day following the expiration of the initial Lock-Up Period, it will give notice
thereof to the Company and the Partnerships and will not consummate such
transaction or take any such action unless it has received written confirmation from the
Company or the Partnerships that the Lock-Up Period (as such may have been extended pursuant to the
previous paragraph) has expired.
Notwithstanding the foregoing, the undersigned may transfer the Undersigned’s Shares (i) as a
bona fide gift or gifts, provided that the donee or donees thereof agree to be bound in writing by
the restrictions set forth herein, (ii) to any trust for the direct or indirect benefit of the
undersigned or the immediate family of the undersigned, provided that the trustee of the trust
agrees to be bound in writing by the restrictions set forth herein, and provided further that any
such transfer shall not involve a disposition for value, (iii) with the prior written consent of
the Representatives on behalf of the Underwriters, or (iv) if such transfer occurs by operation of
laws of descent and distribution, provided that prior to such transfer the transferee
agrees to be bound in writing by the restrictions set forth herein. For purposes of this Lock-Up
Agreement, “immediate family” shall mean any relationship by blood, marriage or adoption, not more
remote than first cousin. In addition, notwithstanding the foregoing, if the undersigned is a
corporation, the corporation may transfer the capital stock of the Company to any wholly-owned
subsidiary of such corporation; provided, however, that in any such case, it shall
be a condition to the transfer that the transferee execute an agreement stating that the transferee
is receiving and holding such capital stock subject to the provisions of this Agreement and there
shall be no further transfer of such capital stock except in accordance with this Agreement, and
provided further that any such transfer shall not involve a disposition for value.
The undersigned now has, and, except as contemplated by clause (i), (ii), or (iii) above, for the
duration of this Lock-Up Agreement will have, good and marketable title to the Undersigned’s
Shares, free and clear of all liens, encumbrances, and claims whatsoever. The undersigned also
agrees and consents to the entry of stop transfer instructions with the transfer agent and
registrar of the Company or any other person against the transfer of the Undersigned’s Shares
except in compliance with the foregoing restrictions.
It is understood that if the Company notifies you in writing that it does not intend to
proceed with the offering, if the Underwriting Agreement does not become effective or if the
Underwriting Agreement (other than provisions thereof which survive termination) shall terminate or
be terminated prior to delivery of the Shares, or if the offering shall not have occurred by June
30, 2007, the undersigned will be released from its obligations under this agreement.
The undersigned understands that the Company, the Partnerships and the Underwriters are
relying upon this Lock-Up Agreement in proceeding toward consummation of the offering. The
undersigned further understands that this Lock-Up Agreement is irrevocable and shall be binding
upon the undersigned’s heirs, legal representatives, successors, and assigns.
Very truly yours, |
||||
By: | ||||
Name: | ||||
Title: | ||||